Article
Mutagenicity of aristolochic acid in the lambda/lacZ transgenic mouse (Muta™Mouse)
Division of Genetics and Mutagenesis, National Institute of Health Sciences, 1-18-1, Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan; Faculty of Pharmaceutical Sciences, Nagoya City University, 3-1, Tanabedouri, Mizuho-ku, Nagoya 467-8603, Japan; Graduate School of Pharmaceutical Sciences, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033 Japan
Mutation Research/Genetic Toxicology and Environmental Mutagenesis
DOI:10.1016/S1383-5718(01)00350-3
pp.63-72
-
Citations (0)
- Cited In (2)
-
Article: In Vitro and In Vivo Genotoxicity Assessment of Aristolochia manshuriensis Kom.
[show abstract] [hide abstract]
ABSTRACT: Arisolochiae species plants containing aristolochic acids I and II (AA I and AA II) are well known to cause aristolochic acid nephropathy (AAN). Recently, there are various approaches to use AAs-containing herbs after the removal of their toxic factors. However, there is little information about genotoxicity of Arisolochiae manshuriensis Kom. (AMK) per se. To obtain safety information for AMK, its genotoxicity was evaluated in accordance with OECD guideline. To evaluate genotoxicity of AMK, we tested bacterial reverse mutation assay, chromosomal aberration test, and micronucleus test. Here, we also determined the amounts of AA I and II in AMK (2.85 ± 0.08 and 0.50 ± 0.02 mg/g extract, resp.). In bacterial reverse mutation assay, AMK dose-dependently increased revertant colony numbers in TA98, TA100 and TA1537 regardless of metabolic activation. AMK increased the incidence of chromosomal aberration in Chinese hamster ovary-K1 cells, but there was no statistically significant difference. The incidences of micronucleus in bone marrow erythrocyte were significantly increased in mice after oral administration of AMK (5000 mg/kg), comparing with those of vehicle group (P < 0.05). The results of three standard tests suggest that the genotoxicity of AMK is directly related to the AAs contents in AMK.Evidence-based Complementary and Alternative Medicine 01/2012; 2012:412736. · 4.77 Impact Factor -
Article: DNA adducts of aristolochic acid II: total synthesis and site-specific mutagenesis studies in mammalian cells.
[show abstract] [hide abstract]
ABSTRACT: Aristolochic acids I and II (AA-I, AA-II) are found in all Aristolochia species. Ingestion of these acids either in the form of herbal remedies or as contaminated wheat flour causes a dose-dependent chronic kidney failure characterized by renal tubulointerstitial fibrosis. In approximately 50% of these cases, the condition is accompanied by an upper urinary tract malignancy. The disease is now termed aristolochic acid nephropathy (AAN). AA-I is largely responsible for the nephrotoxicity while both AA-I and AA-II are genotoxic. DNA adducts derived from AA-I and AA-II have been isolated from renal tissues of patients suffering from AAN. We describe the total synthesis, de novo, of the dA and dG adducts derived from AA-II, their incorporation site-specifically into DNA oligomers and the splicing of these modified oligomers into a plasmid construct followed by transfection into mouse embryonic fibroblasts. Analysis of the plasmid progeny revealed that both adducts blocked replication but were still partly processed by DNA polymerase(s). Although the majority of coding events involved insertion of correct nucleotides, substantial misincorporation of bases also was noted. The dA adduct is significantly more mutagenic than the dG adduct; both adducts give rise, almost exclusively, to misincorporation of dA, which leads to AL-II-dA-->T and AL-II-dG-->T transversions.Nucleic Acids Research 10/2009; 38(1):339-52. · 8.03 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
10 organs
AA induced
AA-treated mice
causes urothelial carcinomas
Chinese herb nephropathy
cII gene
CpG sites predominated
cytochrome P450
form cyclic nitrenium ions
intragastric treatment
lambda/lacZ transgenic mouse
mutations induced
non-target organs
peripheral blood micronucleus assay
phenotypically selectable marker
Sequence analysis
slight increases
T transversions
target organs-forestomach
vivo mutagenicity